Product description
Retatrutide, also identified as LY3437943, is an investigational 39-amino-acid peptide engineered to activate GIP, GLP-1, and glucagon receptors. Laboratory research uses this defined multi-receptor profile to compare pathway balance, receptor crosstalk, and metabolic signaling across in vitro and preclinical models.
The specification record provides the identity, supplied format, available quantities, and storage information needed for procurement review and sample tracking. Researchers are responsible for establishing preparation, concentration, controls, and stability procedures appropriate to their validated methods.
